<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Article Tag Suite 1.1//EN"
  "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         article-type="research-article"
         xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>American Journal of PharmTech Research</journal-title>
        <abbrev-journal-title abbrev-type="publisher">AJPTR</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">2249-3387</issn>
      <publisher>
        <publisher-name>undefined</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">AJPTR72036</article-id>
      <title-group>
        <article-title>In Vitro Aldose Reductase Inhibitory Activity of Some 2,4-Thiazolidinedione Derivatives</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>İŞBİLEN</surname>
            <given-names>Gül A.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>CEYLAN-ÜNLÜSOY</surname>
            <given-names>Meltem</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>SARIKAYA</surname>
            <given-names>Mutlu</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>BOZDAĞ-DÜNDAR</surname>
            <given-names>Oya</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>DAŞ-EVCİMEN</surname>
            <given-names>Net</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">Faculty of Pharmacy, Ankara University, Ankara, Turkey</aff>
      <pub-date pub-type="epub" iso-8601-date="2017-04-01">
        <month>04</month>
        <day>01</day>
        <year>2017</year>
      </pub-date>
      <volume>7</volume>
      <issue>2</issue>
      <abstract>
        <p>Aldose reductase (ALR2; AR; EC 1.1.1.21) is the first enzyme of the polyol pathway, which reduces glucose to sorbitol, in the presence of NADPH. The pathway is completed by sorbitol dehydrogenase, which catalyzes the NAD-linked oxidation of sorbitol to fructose. Synthesis and accumulation of sorbitol in cells due to increased aldose reductase activity is one of the main causes of diabetic complications. The aim of our study is to determine the potential inhibitory effect of some 2, 4-TZD derivatives on aldose reductase enzyme activity. Aldose reductase enzyme is isolated from bovine lenses and the activity of the enzyme is determined by spectrophotometric method. In our study 13 thiazolidinedione (TZD) derivatives which are containing benzyl and phenacyl groups were studied. Maximum inhibitory activity was found with 2,4- TZD-N-unsubstituted compound (86 %).  Compound 13, unsubstituted compound which was showed the maximum inhibitory activity, will be the key formula of our future studies.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>Aldose reductase</kwd>
        <kwd>polyol pathway</kwd>
        <kwd>2</kwd>
        <kwd>4- thiazolidinedione derivatives</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <!-- Full article body not available in metadata-only JATS export. See PDF/HTML galley. -->
  </body>
  <back/>
</article>
